Phase I – Other

1,064 trials 249 recruiting

Filter these 1,064 trials by condition, country, sponsor and more.

Open in Search →

A study to test how well different doses of BI 3031185 are tolerated by healthy men and women Recruiting

2024-516921-29-00 Healthy volunteer trial 2025-03-25
[14C]-BMS986504 Mass Balance Study in Patients with Advanced Solid Tumors with Homozygous MTAP Deletion Recruiting

2024-515518-41-00 Advanced Solid Tumors 2025-03-24
Phase I Study of PM54 Administered to Patients with Advanced Solid Tumors Recruiting

2024-517579-19-00 Selected Advanced Solid Tumors 2025-03-24
Ziftomenib in combination with chemotherapy for children with relapsed/refractory acute leukemia Recruiting

2023-505262-28-00 Acute Myeloid Leukemia 2025-03-24
Biodistribution Evaluation to Reduce Administered Radiopharmaceutical Dose on LOng Axial Field of VieW PET Scanners – BELOW trial Recruiting

2024-512906-24-00 Cancer 2025-03-21
A Study to Test the Activity and Safety of Vixarelimab in Patients with Moderate to Severe Active Ulcerative Colitis Recruiting

2024-516287-29-00 Moderate to Severe Active Ulcerative Colitis (UC) 2025-02-26
Boosting recovery through excitation of arousal and awareness in comatose patients: Dose finding study (BREA2KTHROUGH DOSEFINDER) Recruiting

2023-503617-30-02 Coma and other disorders of consciousness due to acute 2025-02-26
A Phase 1b Study of JNJ-79635322 with Daratumumab With or Without Lenalidomide or JNJ-79635322 with Pomalidomide for Multiple Myeloma Recruiting

2024-515316-44-00 Multiple Myeloma 2025-02-24
INtra-tumor miCro dosIng in PatIents with advanced malignant mElanoma receiving aNti-PD1 Therapy. A pilot study. Recruiting

2023-510544-21-00 Malignant Melanoma 2025-02-18
An open single-center, phase I proof of concept trial to assess the safety and feasibility of adoptive cell therapy with autologous EBV-spec… Recruiting

2024-515563-55-00 Multiple sclerosis 2025-02-17
Multicentric Phase 1 Study With Escalation of Doses of Daratumumab in Combination With Chemotherapy (Idarubicin and Cytarabine) or CPX-351 … Recruiting

2022-502585-25-00 Adult patients with adverse Risk Acute Myeloblastic Leu 2025-02-06
Phase I study of anti-GD2 Chimeric Antigen Receptor-Expressing T cells in pediatric and young adult patients affected by relapsed/refractory… Recruiting

2024-519168-42-00 Relapsed/refractory malignant central nervous system tu 2025-02-05
Measuring the levels of LSD in the human brain using neuroimaging Recruiting

2024-519564-41-00 No medical condition will be examined. 2025-01-22
An Ophthalmic Safety Study of New Investigational Drug in Breast Cancer Patients Recruiting

2024-512161-14-00 Breast Cancer 2025-01-14
IKS03 in Advanced B cell NHL Recruiting

2024-512415-45-00 Advanced B cell Non-Hodgkin Lymphomas 2025-01-14
Takeda Brentuximab; Molecular Imaging of Zirconium-89-labeled Brentuximab as a Tool to Investigate brentuximab biodistribution in CD30-posit… Recruiting

2024-511151-18-01 Patients with stage II-IV high risk diffuse large B-cel 2025-01-02
An Open-Label, Rollover Platform Study for Continued Study Treatment and Ongoing Safety Monitoring Recruiting

2024-515457-21-00 Non-Hodgkin lymphoma and chronic lymphocytic leukemia 2024-12-30
clinical trial to determine the feasibility and safety of the mesenchymal stem cells use in women over 50 years of age with urinary incontin… Recruiting

2024-514833-39-00 Stress or mixed urinary incontinence in women over 50 y 2024-12-16
The detection of tumor-associated fibrosis in colorectal peritoneal metastases by FAPI-PET (TROMPET) Recruiting

2024-512301-16-01 Metastatic colorectal cancer 2024-12-12
A Study to Assess Distribution, Binding, and Retention of the Monoclonal Antibody Trontinemab in the Brain of Healthy Participants and Patie… Recruiting

2023-509900-14-00 Alzheimer’s Disease (AD) 2024-12-10
Detection of tumor tiSsue in pEritoneal metastases of coLorectal origin using a VEGF-targeted optical fluoresCent imaging tracer during diag… Recruiting

2024-517718-13-01 peritoneal metastases of colorectal origin 2024-11-25
Subcutaneous Tarlatamab in Subjects with Extensive Stage Small Cell Lung Cancer (DeLLphi-308) Recruiting

2024-511838-12-00 Extensive Stage Small Cell Lung Cancer (DeLLphi-308) 2024-11-22
A phase IB clinical trial on neoadjuvant and intraoperative intracranial administration of triple immune checkpoint blockade plus myeloid d… Recruiting

2024-517842-33-01 glioblastoma 2024-11-20
Normothermic intraperitoneal chemotherapy – long term in peritoneal metastases from colorectal cancer – feasibility study Recruiting

2023-510217-26-00 colorectal cancer with peritoneal metastasis 2024-11-14